Sandostatin and disease progression Patient Reports February 10, 2010

Sandostatin Side Effects Report #6021580-9
Sandostatin side effect was reported by a Health Professional from ISRAEL on Dec 24, 2008. Female patient, 80 years of age, was diagnosed with neuroendocrine carcinoma of the skin and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: disease progression. Sandostatin dosage: 30 MG, UNK. Patient died.

Sandostatin Side Effects Report #4944980-4
Sandostatin side effect was reported by a Physician from UNITED STATES on July 27, 2005. Male patient, 79 years of age, was diagnosed with neuroendocrine carcinoma and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: disease progression, neuroendocrine carcinoma. Sandostatin dosage: unknown. Patient died on 11/01/2004.

Sandostatin Side Effects Report #4906187-6
Sandostatin side effect was reported by a Physician from UNITED STATES on July 19, 2002. Male patient, 56 years of age, weighting 179.9 lb, was diagnosed with diabetic retinopathy and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, blood pressure abnormal, bradycardia, cardiac arrest , cholecystectomy, cholecystitis, cholelithiasis, disease progression. Sandostatin dosage: 30 MG, UNK. During the same period patient was treated with GLUCOPHAGE, LOTENSIN, GLYBURIDE, LOPRESSOR, FLAGYL. Patient was hospitalized. Patient died on 08/13/2002.

Sandostatin Side Effects Report #4614810-9
Sandostatin side effect was reported by a Pharmacist from on Nov 09, 2004. Male patient, child 1 years of age, weighting 17.64 lb, was diagnosed with chylothorax and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: atrioventricular block second degree, disease progression, hypertrophic cardiomyopathy, metabolic disorder , mitral valve stenosis. Sandostatin dosage: unknown. Patient died on 03/10/2005.


Sandostatin Side Effects Report #5412046-5
Sandostatin side effect was reported by a Consumer or non-health professional from CANADA on Aug 03, 2007. Female patient, 68 years of age, was diagnosed with carcinoid tumour and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: abdominal neoplasm, cystitis, disease progression, fallopian tube cancer, intestinal obstruction, lethargy, ovarian cancer, pelvic neoplasm, pneumonia . Sandostatin dosage: 60 MG EVERY 4 WEEKS. During the same period patient was treated with SANDOSTATIN LAR, ATENOLOL, INHIBACE, OXAZEPAM. Patient was hospitalized. Patient recovered.

Sandostatin Side Effects Report #5888858-0
Sandostatin side effect was reported by a Consumer or non-health professional from CANADA on Sept 10, 2008. Female patient was diagnosed with carcinoid tumour and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: abdominal neoplasm, bone pain, chest wall mass, cystitis, disease progression, fallopian tube cancer, intestinal obstruction, lethargy, ovarian cancer. Sandostatin dosage: 60 MG EVERY 3 WEEKS. During the same period patient was treated with SANDOSTATIN LAR, ATENOLOL, INHIBACE, OXAZEPAM. Patient was hospitalized. Patient recovered.

Sandostatin Side Effects Report #5922604-7
Sandostatin side effect was reported by a Consumer or non-health professional from CANADA on Oct 15, 2008. Female patient was diagnosed with carcinoid tumour and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: ascites, bile duct stent insertion, body temperature increased, disease progression, dyspnoea exertional, oedema peripheral, paracentesis. Sandostatin dosage: 40 MG EVERY 3 WEEKS. Patient died on 10/12/2008.

Sandostatin Side Effects Report #6089605-2
Sandostatin side effect was reported by a Consumer or non-health professional from on Feb 17, 2009. Female patient was diagnosed with carcinoid tumour and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: abdominal pain upper, asthenia, diarrhoea, disease progression, dyspepsia, fatigue, fluid intake reduced, hypophagia, memory impairment. Sandostatin dosage: 40 MG, QMO. During the same period patient was treated with SANDOSTATIN LAR. Patient was hospitalized. Patient recovered.

Sandostatin Side Effects Report #4574197-7
Sandostatin side effect was reported by a Physician from on Nov 18, 2004. Female patient was diagnosed with carcinoid tumour and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: disease progression, metastatic neoplasm, neutropenia, pneumonia . Sandostatin dosage: 40 MG, QMO. Patient died on 02/29/2004.


Sandostatin Side Effects Report #5304285-9
Sandostatin side effect was reported by a Health Professional from CANADA on Apr 10, 2007. Male patient, 78 years of age, was diagnosed with carcinoid syndrome and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: blood pressure increased, diarrhoea, disease progression, fatigue, flushing, hepatic neoplasm, hormone level abnormal, malaise, therapeutic embolisation. Sandostatin dosage: 40 MG, QMO. During the same period patient was treated with SANDOSTATIN LAR. Patient was hospitalized. Patient recovered.

Sandostatin Side Effects Report #5079799-X
Sandostatin side effect was reported by a Health Professional from UNITED STATES on May 15, 2006. Male patient, 75 years of age, was diagnosed with carcinoid syndrome, hypertension, benign prostatic hyperplasia and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: agitation, carcinoid syndrome, confusional state, disease progression, disorientation, dizziness , hallucination, hypertension, lethargy. Sandostatin dosage: 30 MG, QMO. During the same period patient was treated with TOPROL, AMLODIPINE BESYLATE, FLOMAX, LESCOL. Patient was hospitalized. Patient died on 07/14/2006.

Sandostatin Side Effects Report #4981643-3
Sandostatin side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 19, 2006. Male patient, 55 years of age, was diagnosed with carcinoid syndrome and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: disease progression, hepatic failure. Sandostatin dosage: unknown. Patient died on 09/01/2004.

Sandostatin Side Effects Report #5570416-9
Sandostatin side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 11, 2007. Female patient, 54 years of age, was diagnosed with carcinoid syndrome and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: arthralgia, arthritis , bone pain, disease progression, eye swelling, hypokinesia, injection site erythema, injection site oedema, injection site pruritus. Sandostatin dosage: unknown. During the same period patient was treated with SANDOSTATIN LAR, ADVIL LIQUI. Patient recovered.

Sandostatin Side Effects Report #5590897-4
Sandostatin side effect was reported by a Health Professional from UNITED STATES on Aug 08, 2007. Female patient, 54 years of age, was diagnosed with carcinoid syndrome and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: arthralgia, arthritis , asthenia, bone pain, disease progression, eye swelling, hypokinesia, musculoskeletal stiffness, oedema peripheral. Sandostatin dosage: unknown. During the same period patient was treated with SANDOSTATIN LAR, ADVIL, VICODIN. Patient recovered.


Sandostatin Side Effects Report #4582727-4
Sandostatin side effect was reported by a Consumer or non-health professional from on Jan 27, 2004. Female patient, 53 years of age, was diagnosed with acromegaly and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: disease progression, swollen tongue, throat tightness. Sandostatin dosage: 20 MG, QMO, INJECTION NOS. During the same period patient was treated with PARLODEL. Patient recovered.

Sandostatin Side Effects Report #5338007-2
Sandostatin side effect was reported by a Consumer or non-health professional from UNITED STATES on May 20, 2007. Male patient was diagnosed with acromegaly and was treated with Sandostatin. After drug was administered, patient experienced the following side effects: disease progression, insulin-like growth factor increased, ventricular hypertrophy. Sandostatin dosage: 30 MG Q28DAYS. Patient recovered.

Sandostatin Side Effects Report #5775467-7
Sandostatin side effect was reported by a Physician from ISRAEL on June 15, 2008. Female patient, 67 years of age, was treated with Sandostatin. After drug was administered, patient experienced the following side effects: disease progression, pneumonia aspiration. Sandostatin dosage: 30 MG, ONCE/SINGLE. During the same period patient was treated with ANTIBIOTICS. Patient died.

Sandostatin Side Effects Report #5926717-5
Sandostatin side effect was reported by a Physician from BRAZIL on Oct 22, 2008. Female patient, weighting 173.5 lb, was treated with Sandostatin. After drug was administered, patient experienced the following side effects: cholelithiasis, condition aggravated, disease progression, nausea . Sandostatin dosage: 30 MG. Patient recovered.

Sandostatin Side Effects Report #6114438-8
Sandostatin side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 09, 2009. Female patient was treated with Sandostatin. After drug was administered, patient experienced the following side effects: aspiration, bone pain, disease progression. Sandostatin dosage: unknown. Patient died on 12/16/2008.